Industry News

Mar 10, 2015

VolitionRx initiates second prostate cancer pilot study assessing Nucleosomics(R) technology

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has initiated a pilot... Read More
Mar 10, 2015

Thyroid nodule identification: new data supporting use of ThyraMIR announced

PDI, Inc. subsidiary, Interpace Diagnostics, has announced new data supporting the use of combination platform testing with ThyraMIR, the first and only microRNA expression classifier, and ThyGenX... Read More
Mar 10, 2015

The Universitat Politècnica de València is coordinating a European project to develop a device for the quick and early diagnosis of cancer

To develop a device based on nanophotonic technology that enables a quick and early diagnosis of different types of cancer - specifically breast, prostate, lung and colorectal - analysing only two... Read More
Mar 10, 2015

New breast density technology debuts at ECR Conference

A new research technology was profiled today during scientific sessions at the European Congress of Radiology (ECR) in Vienna, Austria. Read More
Mar 10, 2015

"Systems-based" hematologist represents new way to provide hematology expertise

A report released from the American Society of Hematology (ASH) in its journal, Blood, presents an innovative, sustainable new role for hematologists, particularly those specializing in... Read More
Mar 10, 2015

Medical nanoparticles: Local treatment of lung cancer

Nanoparticles are extremely small particles that can be modified for a variety of uses in the medical field. Read More
Mar 10, 2015

Safer drug combination found for patients with high-risk atrial fibrillation

Newer blood-thinner a better option for some patientsPatients with high-risk atrial fibrillation, or AFib, often require one drug to regulate heart rhythm and a second drug to thin their blood... Read More
Mar 10, 2015

Study links vegetarian diet to reduced risk of colorectal cancer

Eating a vegetarian diet may reduce the risk of developing colorectal cancer by 22%, with a pescovegetarian diet alone almost halving risk of the disease, according to a new study. Read More
Mar 10, 2015

Unregulated web marketing of genetic tests for personalized cancer care raises concerns

Websites that market personalized cancer care services often overemphasize their purported benefits and downplay their limitations, and many sites offer genetic tests whose value for guiding cancer... Read More
Mar 10, 2015

Products advertised on personalized cancer care websites: True or false claims?

Although there are only a few validated genetic tests specifying individual risks for certain cancers or which can help to select genomically targeted cancer therapies, the Internet is already a... Read More
Next Page